Yinghua Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yinghua Zou has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Haitao Guan
Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China
4 shared publications Jian Wang
Peking University First Hospital
4 shared publicationsXiaoqiang Tong
Peking University First Hospital
4 shared publicationsGuoxiang Wang
Yijishan Hospital of Wannan Medical College
2 shared publicationsLetao Lin
Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, P.R. China
2 shared publicationsMin Yang
Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China (all authors)
2 shared publications
Latest Publications
- Open Access
- 18 April 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (S1) , 254-258
Endovascular Removal of Foreign Bodies: Single Center Experience
Catheter rupture or displacement is a serious and rare complication of central venous catheterization, with an incidence of approximately 1%. Once the intravascular foreign body is found, it should be removed as soon as possible. This study investigated the safety and efficacy of endovascular techniques for the removal of intravascular foreign bodies. This was a retrospective analysis of 23 patients with intravascular foreign bodies admitted to our hospital from January 2009 to June 2019 summarizing the types and locations of foreign bodies and the removal techniques. Overall Twenty-three cases of intravascular foreign bodies were successfully treated with endovascular techniques, for a technical success rate of 100%. The types of foreign bodies included 14 infusion port catheters (60.9%), 6 peripherally inserted central catheters (26.1%), 2 temporary deep vein catheters (8.7%), and 1 intravenous stent (4.3%). The most common orientation of foreign body displacement was one end of the foreign body in the inferior vena cava and the other end in the right atrium (14/23, 60.9%). In terms of technique, all patients underwent removal procedures with only one venous access point. The operative time ranged from 6 to 153 min, with an average of 28.7 min. This study preliminarily demonstrates the safety and efficacy of percutaneous interventional intravascular foreign body removal. Endovascular techniques are minimally invasive and reliable and can be used to safely and effectively remove intravascular foreign bodies.
- 18 April 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (S1) , 254-258
Open AccessEndovascular Removal of Foreign Bodies: Single Center Experience
Catheter rupture or displacement is a serious and rare complication of central venous catheterization, with an incidence of approximately 1%. Once the intravascular foreign body is found, it should be removed as soon as possible. This study investigated the safety and efficacy of endovascular techniques for the removal of intravascular foreign bodies. This was a retrospective analysis of 23 patients with intravascular foreign bodies admitted to our hospital from January 2009 to June 2019 summarizing the types and locations of foreign bodies and the removal techniques. Overall Twenty-three cases of intravascular foreign bodies were successfully treated with endovascular techniques, for a technical success rate of 100%. The types of foreign bodies included 14 infusion port catheters (60.9%), 6 peripherally inserted central catheters (26.1%), 2 temporary deep vein catheters (8.7%), and 1 intravenous stent (4.3%). The most common orientation of foreign body displacement was one end of the foreign body in the inferior vena cava and the other end in the right atrium (14/23, 60.9%). In terms of technique, all patients underwent removal procedures with only one venous access point. The operative time ranged from 6 to 153 min, with an average of 28.7 min. This study preliminarily demonstrates the safety and efficacy of percutaneous interventional intravascular foreign body removal. Endovascular techniques are minimally invasive and reliable and can be used to safely and effectively remove intravascular foreign bodies.
- Open Access
- 22 December 2021
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 39 (1) , 1-7
Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression
To compare the long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation (TACE-RFA) with radiofrequency ablation (RFA) monotherapy for small (≤3 cm) hepatocellular ...
- 22 December 2021
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 39 (1) , 1-7
Open AccessLong-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression
To compare the long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation (TACE-RFA) with radiofrequency ablation (RFA) monotherapy for small (≤3 cm) hepatocellular ...
- Open Access
- 10 February 2021
- Published by Springer Nature in Research Square
Efficacy and Safety Comparison between Drug-eluting Beads CalliSpheres and Conventional Transcatheter Arterial Chemoembolization in Treating Renal Angiomyolipoma Patients
Background: There is a lack of evidence of standard or superior treatment among renal angiomyolipoma (RAML) patients. This study aimed to compare the short-term efficacy and safety using CalliSpheres microspheres (CSM) with conventional transcatheter arterial chemoembolization (cTACE) in treating Chinese patients with RAML. Methods: A total of 54 patients with RAML treated by TACE from February 2018 to April 2020 were retrospectively analyzed. These included 17 cases in the CSM-TACE group and 37 cases in the cTACE group. The clinical efficacy, tumor reduction rate and complications were compared between the two groups. Furthermore, blood routine indexes and kidney function test were compared between the two groups before and at the third day after the operation. Results: The embolization was performed successfully in all patients without serious adverse events and death. Except for abdominal pain (p=0.044) and white blood cell (WBC) (p=0.047), there were no significant differences in baseline characteristics (p>0.05). As for treatment efficacy, 42 patients with RAML had tumor size reduced after embolization. Compared with CSM-TACE group (0.12±0.34), tumor volume reduction rate was slightly higher in cTACE group (0.32±0.31) with p value 0.047. As for treatment safety, postoperative WBC and creatine level in two groups were both in normal range and not significantly different (p=0.114 and 0.659). Besides, no significant differences were observed in complication and length of stay after the operation between the two groups (p=0.347 and 0.593).Conclusions: CSM could be a safe and good option for embolization therapy in treating Chinese patients with RAML in clinical practices. Large cohort perspective study is still needed in the future.
- 10 February 2021
- Published by Springer Nature in Research Square
Open AccessEfficacy and Safety Comparison between Drug-eluting Beads CalliSpheres and Conventional Transcatheter Arterial Chemoembolization in Treating Renal Angiomyolipoma Patients
Background: There is a lack of evidence of standard or superior treatment among renal angiomyolipoma (RAML) patients. This study aimed to compare the short-term efficacy and safety using CalliSpheres microspheres (CSM) with conventional transcatheter arterial chemoembolization (cTACE) in treating Chinese patients with RAML. Methods: A total of 54 patients with RAML treated by TACE from February 2018 to April 2020 were retrospectively analyzed. These included 17 cases in the CSM-TACE group and 37 cases in the cTACE group. The clinical efficacy, tumor reduction rate and complications were compared between the two groups. Furthermore, blood routine indexes and kidney function test were compared between the two groups before and at the third day after the operation. Results: The embolization was performed successfully in all patients without serious adverse events and death. Except for abdominal pain (p=0.044) and white blood cell (WBC) (p=0.047), there were no significant differences in baseline characteristics (p>0.05). As for treatment efficacy, 42 patients with RAML had tumor size reduced after embolization. Compared with CSM-TACE group (0.12±0.34), tumor volume reduction rate was slightly higher in cTACE group (0.32±0.31) with p value 0.047. As for treatment safety, postoperative WBC and creatine level in two groups were both in normal range and not significantly different (p=0.114 and 0.659). Besides, no significant differences were observed in complication and length of stay after the operation between the two groups (p=0.347 and 0.593).Conclusions: CSM could be a safe and good option for embolization therapy in treating Chinese patients with RAML in clinical practices. Large cohort perspective study is still needed in the future.
- Open Access
- 22 September 2020
- Published by Springer Nature in Research Square
Synergistic Effect of PD-L1 and HLA Class I On Prognosis of Patients With Hepatocellular Carcinoma
Background: Up-regulating the expression of PD-L1 and down-regulating the expression of HLA class I are the two main means of tumor-induced immune tolerance. The purpose of this study is to explore whether there is synergistic effect of up-regulation of PD-L1 and down-regulation of HLA-I on prognosis in hepatocellular carcinoma (HCC). Methods: A cohort of 185 consecutive HCC patients was included in this study. According to the expression of PD-L1 and HLA class I, patients were divided into three subgroups: group A was PD-L1 negative + HLA class I high expression, group B was PD-L1 positive + HLA class I high expression or PD-L1 negative + HLA class I low expression, group C was PD-L1 positive + HLA class I low expression. Results: PD-L1 positive was significantly associated with cirrhosis and tumor-infiltrating lymphocytes (P = 0.026; P= 0.000, respectively). Neither of PD-L1 positive and HLA class I low expression was significantly associated with shorter survival patients (P = 0.116; P = 0.171, respectively). The overall survival time of group C was significantly lower than that of group A and group B (31 months vs 58 months vs 49 months, P = 0.004), which was further confirmed by multivariate Cox regression analysis (group A/B vs group C, HR 3.652, 95%CI 1.627-8.200, P= 0.002). Conclusions: The synergistic effect of PD-L1 positive and HLA class I low expression could result into a significant reduction in survival of patients with HCC, providing theoretical support for the combination of immunotherapy in future.
- 22 September 2020
- Published by Springer Nature in Research Square
Open AccessSynergistic Effect of PD-L1 and HLA Class I On Prognosis of Patients With Hepatocellular Carcinoma
Background: Up-regulating the expression of PD-L1 and down-regulating the expression of HLA class I are the two main means of tumor-induced immune tolerance. The purpose of this study is to explore whether there is synergistic effect of up-regulation of PD-L1 and down-regulation of HLA-I on prognosis in hepatocellular carcinoma (HCC). Methods: A cohort of 185 consecutive HCC patients was included in this study. According to the expression of PD-L1 and HLA class I, patients were divided into three subgroups: group A was PD-L1 negative + HLA class I high expression, group B was PD-L1 positive + HLA class I high expression or PD-L1 negative + HLA class I low expression, group C was PD-L1 positive + HLA class I low expression. Results: PD-L1 positive was significantly associated with cirrhosis and tumor-infiltrating lymphocytes (P = 0.026; P= 0.000, respectively). Neither of PD-L1 positive and HLA class I low expression was significantly associated with shorter survival patients (P = 0.116; P = 0.171, respectively). The overall survival time of group C was significantly lower than that of group A and group B (31 months vs 58 months vs 49 months, P = 0.004), which was further confirmed by multivariate Cox regression analysis (group A/B vs group C, HR 3.652, 95%CI 1.627-8.200, P= 0.002). Conclusions: The synergistic effect of PD-L1 positive and HLA class I low expression could result into a significant reduction in survival of patients with HCC, providing theoretical support for the combination of immunotherapy in future.
- Open Access
- 21 March 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (4) , 1417-1428
Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis
Objective: The present study aimed to evaluate renal function, complications, and changes in tumor size after transarterial embolization for patients with renal angiomyolipomas. Methods: We performed a meta-analysis of transarterial embolization in patients with renal angiomyolipomas from January 1994 to April 2018. Endpoints of interest were the estimated glomerular filtration rate, serum creatinine levels, blood urea nitrogen levels, complications, and reduction of tumors. Results: A total of 30 studies comprising 653 patients were included. A total of 32.0% of patients were treated by urgent transarterial embolization for spontaneous ruptured renal angiomyolipomas. Other patients sought to relieve symptoms or received embolism prophylactically. The estimated glomerular filtration rate showed no significant difference between before and after embolization. In 363 patients with data on complications, post-embolization syndrome occurred most frequently (54.0%). Only 16 (4.4%) patients had major complications. The diameter of sporadic angiomyolipomas was reduced by a mean of 2.09 cm (95% confidence interval [CI], 0.73–3.45 cm; I 2 = 29.3%) and they were reduced in size by 30.0% (95% CI, 16.0%–44.0%; I 2 = 27.9%). Conclusions: Transarterial embolization of renal angiomyolipomas affects renal function preservation, with a low complication rate. Transarterial embolization is useful for sporadic and tuberous sclerosis complex-related angiomyolipomas.
- 21 March 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (4) , 1417-1428
Open AccessRenal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis
Objective: The present study aimed to evaluate renal function, complications, and changes in tumor size after transarterial embolization for patients with renal angiomyolipomas. Methods: We performed a meta-analysis of transarterial embolization in patients with renal angiomyolipomas from January 1994 to April 2018. Endpoints of interest were the estimated glomerular filtration rate, serum creatinine levels, blood urea nitrogen levels, complications, and reduction of tumors. Results: A total of 30 studies comprising 653 patients were included. A total of 32.0% of patients were treated by urgent transarterial embolization for spontaneous ruptured renal angiomyolipomas. Other patients sought to relieve symptoms or received embolism prophylactically. The estimated glomerular filtration rate showed no significant difference between before and after embolization. In 363 patients with data on complications, post-embolization syndrome occurred most frequently (54.0%). Only 16 (4.4%) patients had major complications. The diameter of sporadic angiomyolipomas was reduced by a mean of 2.09 cm (95% confidence interval [CI], 0.73–3.45 cm; I 2 = 29.3%) and they were reduced in size by 30.0% (95% CI, 16.0%–44.0%; I 2 = 27.9%). Conclusions: Transarterial embolization of renal angiomyolipomas affects renal function preservation, with a low complication rate. Transarterial embolization is useful for sporadic and tuberous sclerosis complex-related angiomyolipomas.
- 1 March 2019
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 26 (3) , 409-416
Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis
- 1 March 2019
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 26 (3) , 409-416
Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis
- 3 January 2019
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 276 (3) , 865-869
Efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam for nasopharyngeal angiofibroma
To investigate the efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam particles in patients with nasopharyngeal angiofibroma.
- 3 January 2019
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 276 (3) , 865-869
Efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam for nasopharyngeal angiofibroma
To investigate the efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam particles in patients with nasopharyngeal angiofibroma.
- Open Access
- 1 June 2017
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (22) , e6969
Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation
Perivascular epithelioid cell tumors (PEComas) are extremely rare mesenchymal entities with potentially malignant properties; the liver cases are not encountered frequently. Owing to themalignant potential, these tumors are treated by surgical methods to ensure total resection. In the present report, a case of liver PEComa treated by embolization combined with radiofrequency ablation (RFA) has been described. A 40-year-old female was admitted for the detection of a liver mass during an annual physical examination. The patient did not have any liver disease background, enhanced computed tomography (CT), and magnetic resonance revealed a huge mass in the right lobe. Pathology gave the diagnosis of PEComa, for disagreement of open surgery, a combination of transarterial embolization (TAE) and RFA were applied for treatment and the outcomes were acceptable, the patient was under follow-up to observe the long-term effect. Interventional procedures such as TAE and RFA are feasible and effective for such lesions and may serve as an alternate when resection is not indicated. Prospective studies are warranted to verify the long-term outcomes.
- 1 June 2017
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (22) , e6969
Open AccessHepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation
Perivascular epithelioid cell tumors (PEComas) are extremely rare mesenchymal entities with potentially malignant properties; the liver cases are not encountered frequently. Owing to themalignant potential, these tumors are treated by surgical methods to ensure total resection. In the present report, a case of liver PEComa treated by embolization combined with radiofrequency ablation (RFA) has been described. A 40-year-old female was admitted for the detection of a liver mass during an annual physical examination. The patient did not have any liver disease background, enhanced computed tomography (CT), and magnetic resonance revealed a huge mass in the right lobe. Pathology gave the diagnosis of PEComa, for disagreement of open surgery, a combination of transarterial embolization (TAE) and RFA were applied for treatment and the outcomes were acceptable, the patient was under follow-up to observe the long-term effect. Interventional procedures such as TAE and RFA are feasible and effective for such lesions and may serve as an alternate when resection is not indicated. Prospective studies are warranted to verify the long-term outcomes.